ArticleBritish journal of cancer2019

Enhanced antitumor effect of binimetinib in combination with capecitabine for biliary tract cancer patients with mutations in the RAS/RAF/MEK/ERK pathway: phase Ib study.

Jin Won Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.